Logo image of IFBD

INFOBIRD CO LTD (IFBD) Stock Fundamental Analysis

NASDAQ:IFBD - Nasdaq - KYG477243003 - Common Stock - Currency: USD

1  -0.01 (-0.99%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IFBD. IFBD was compared to 282 industry peers in the Software industry. IFBD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IFBD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IFBD had negative earnings in the past year.
In the past year IFBD has reported a negative cash flow from operations.
In the past 5 years IFBD reported 4 times negative net income.
In the past 5 years IFBD reported 4 times negative operating cash flow.
IFBD Yearly Net Income VS EBIT VS OCF VS FCFIFBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.85%, IFBD is in line with its industry, outperforming 55.67% of the companies in the same industry.
IFBD has a Return On Equity of -3.24%. This is in the better half of the industry: IFBD outperforms 62.41% of its industry peers.
Industry RankSector Rank
ROA -2.85%
ROE -3.24%
ROIC N/A
ROA(3y)-33.03%
ROA(5y)-24.55%
ROE(3y)-79.95%
ROE(5y)-56.26%
ROIC(3y)N/A
ROIC(5y)N/A
IFBD Yearly ROA, ROE, ROICIFBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

With a Gross Margin value of 41.21%, IFBD is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IFBD has declined.
The Profit Margin and Operating Margin are not available for IFBD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.57%
GM growth 5Y-6.03%
IFBD Yearly Profit, Operating, Gross MarginsIFBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

6

2. Health

2.1 Basic Checks

IFBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
IFBD has more shares outstanding than it did 1 year ago.
IFBD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for IFBD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IFBD Yearly Shares OutstandingIFBD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
IFBD Yearly Total Debt VS Total AssetsIFBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.09, we must say that IFBD is in the distress zone and has some risk of bankruptcy.
IFBD has a Altman-Z score of 0.09. This is in the lower half of the industry: IFBD underperforms 70.92% of its industry peers.
IFBD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACC11.03%
IFBD Yearly LT Debt VS Equity VS FCFIFBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.63 indicates that IFBD has no problem at all paying its short term obligations.
The Current ratio of IFBD (2.63) is better than 71.99% of its industry peers.
IFBD has a Quick Ratio of 2.63. This indicates that IFBD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.63, IFBD is in the better half of the industry, outperforming 72.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.63
IFBD Yearly Current Assets VS Current LiabilitesIFBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

IFBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.36%, which is quite impressive.
The Revenue has grown by 413.54% in the past year. This is a very strong growth!
IFBD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -39.84% yearly.
EPS 1Y (TTM)99.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.95%
Revenue 1Y (TTM)413.54%
Revenue growth 3Y-46.97%
Revenue growth 5Y-39.84%
Sales Q2Q%406.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IFBD Yearly Revenue VS EstimatesIFBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IFBD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IFBD Price Earnings VS Forward Price EarningsIFBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IFBD Per share dataIFBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IFBD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INFOBIRD CO LTD

NASDAQ:IFBD (5/30/2025, 9:43:03 AM)

1

-0.01 (-0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-10 2025-04-10
Earnings (Next)N/A N/A
Inst Owners0.04%
Inst Owner Change-0.28%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.19M
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.7
P/FCF N/A
P/OCF N/A
P/B 0.13
P/tB 3.5
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0.18
BVpS7.91
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.85%
ROE -3.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.21%
FCFM N/A
ROA(3y)-33.03%
ROA(5y)-24.55%
ROE(3y)-79.95%
ROE(5y)-56.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.57%
GM growth 5Y-6.03%
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 680.35%
Cap/Sales 53.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.63
Altman-Z 0.09
F-Score3
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)413.54%
Revenue growth 3Y-46.97%
Revenue growth 5Y-39.84%
Sales Q2Q%406.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.18%
OCF growth 3YN/A
OCF growth 5YN/A